Idiopathic CD4+ Lymphocytopenia Associated with Evans’ Syndrome: A Case Report

Ines Safra^1, , Imene Namouchi¹, HMC Laboratory¹, Salem Abbes¹ and Samia Mnif¹

¹University of Tunis El Manar, Medecine Tunis Faculty, HMC Laboratory, Pasteur Institute of Tunisia

Cite this paper:
Ines Safra, Imene Namouchi, HMC Laboratory, Salem Abbes and Samia Mnif. Idiopathic CD4+ Lymphocytopenia Associated with Evans’ Syndrome: A Case Report. International Journal of Hematological Disorders. 2017; 3(1):1-2. doi: 10.12691/ijhd-3-1-1

Abstract

Idiopathic CD4+ lymphocytopenia (ICL) is a syndrome first defined in 1992 by the Centers for Disease Control and Prevention (CDCP) as “a documented absolute CD4 T lymphocyte count of less than 300 cells per cubic millimeter or of less than 20% of total T cells on more than one occasion, no evidence of infection on HIV testing and the absence of any defined immunodeficiency or therapy associated with depressed levels of CD4 T cells”. The clinical course, immunologic characteristics, CD4 T cell kinetics, long term outcome and prognosis of this syndrome remain poorly defined but it is widely accepted that ICL is a rare, heterogeneous syndrome, usually detected after the occurrence of an opportunistic infection in a person without known immunodeficiency or immunodepression although it can also be an incidental laboratory finding. Autoimmune phenomena are common in this syndrome. In this article, we reported a case diagnosed with an Evans’ syndrome and that fulfilled the CDCP definition of ICL.

Keywords:
thrombocytopenia anemia immune defeciency Fow cytometry

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Dimitrios I.Zonios, Judith Falloon, John E. Bennet, Pamela A. Shaw, Doreen Chaitt, Michael W. Baseler, Joseph W. Adelsberger, Julia A. Metcalf, Michael A. Polis, Stephen J. Kovacs, Joseph A. Kovacs, Richard T. Davey, H. Clifford Lane, Henry Masur and Irini Sereti, “Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors”, Blood ,112 (2), 287-294, Jul 2008.
[2]	Mario Ostrowski, Irving E. Salit, Wayne L. Gold, David Sutton, Michael L. Montpetit, Debbie Lepine, Teresa Salas, “Idiopathic CD4+ T-lymphocytopenia in two patients” CMAJ, 149 (11), 1679-83, Dec 1993.
[3]	Marina Karakantza, Athanasia Mouzaki, Maria Theodorooulou, James B. Bussel and Alice Maniatis, “Th1 and Th2 cytokines in a patient with Evans’ syndrome and profound lymphopenia”, Br J Haematol,110(4): 968-970, Sep 2000.
[4]	A. Guffroy, V. Gies, M. Martin, A-S. Korganow, “Primary immunodeficiency and autoimmunity”, Rev Med Interne Nov 2016.
[5]	Alexander Khaoruts, Joanne M. Fraser, “A causal link between lymphopenia and autoimmunity” Immunol Lett, 98 (1), 23-31, Apr 2005.
[6]	A. Régent, N. Kluger, A. Bérezné, K. Lassoued, L. Mouthon, “Lymphocytopenia: A etiology and diagnosis, when to think about idiopathic CD4+ lymphocytopenia?” Rev Med Interne, 33(11), 628-34 Nov 2012.
[7]	Kirtava Z, Blomberg J, Bredberg A, Henriksson G, Jacobsson L,Manthorpe R, “ CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjogren’s syndrome” , Clin Exp Rheumatol 13(5), 609-16,Sep-Oct 1995.
[8]	Armelle Le Campion, “Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development” Blood, 114(9), 27 Aug 2009.
[9]	Gholamin M1, Bazi A, Abbaszadegan MR, “Idiopathic lymphocytopenia”, Curr Opin Hematol, 22(1), 46-52, Jan 2015.
[10]	Brooks JP, Ghaffari G, “Idiopathic CD4 lymphocytopenia”, Allergy Asthma Proc, 37(6), 501-504, Nov 2016.
[11]	Angela Malaspina, Susan Moir, Doreen G. Cahitt, Catherine A. Rehm, Shyam Kottili, Judith Falloon, Antony S. Fauci, “Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7” Blood 109 (5): 2086-2088, Mar 2007.